Process not transferable during regulatory submission – ICH Q8/Q11 alignment strategy


Published on 25/04/2026

Developing a Strategy for Non-Transferable Processes in Regulatory Submissions

The pharmaceutical industry faces significant challenges when processes are deemed non-transferable during regulatory submissions, especially under guidelines set forth by ICH Q8/Q11. This issue can result in delays, increased costs, and complications during scale-up activities. In this article, we will provide a comprehensive playbook for identifying, analyzing, and mitigating risks associated with non-transferable processes. By following actionable steps tailored to different roles within your organization, you will be equipped to enhance your development strategy, ensure regulatory compliance, and effectively manage CMC risks.

From immediate containment actions to long-term strategies for control and inspection readiness, this playbook outlines the necessary steps to navigate the complexities of formulation and process development in the context of FDA, EMA, and ICH expectations.

Symptoms/Signals on the Floor or in the Lab

Identifying symptoms of non-transferable processes early can prevent larger issues down the line. Common signals include:

  • Inconsistent product quality or performance when scaled up.
  • Increased frequency of deviations in batch records.
  • Challenges during technology transfer sessions; discrepancies noted in performance metrics.
  • Inadequate
correlation of process parameters between pilot and production scales.
  • Failure to replicate critical quality attributes (CQAs).
  • Each of these symptoms warrants immediate investigation to determine underlying causes and take corrective actions. Documenting these signals will also contribute to inspection readiness.

    Likely Causes (by category: Materials, Method, Machine, Man, Measurement, Environment)

    Understanding the likely causes of transfers failing during regulatory submission can help streamline your response. Below is a categorization based on the commonly referred ‘6 M’s’ framework:

    Category Likely Cause
    Materials Inconsistency in raw material properties or suppliers’ specifications.
    Method Process conditions not adequately defined or characterized.
    Machine Shortcomings in equipment capabilities or calibration issues.
    Man Lack of training or experience among personnel performing critical tasks.
    Measurement Measurement system fluctuations affecting data integrity.
    Environment Uncontrolled environmental factors (temperature, humidity) impacting processes.

    Each cause must be thoroughly investigated to identify the specific failure mechanisms that affect process transferability.

    Immediate Containment Actions (first 60 minutes)

    Upon recognizing symptoms of non-transferability, the first 60 minutes are critical for containing the issue:

    1. Stop Production: Cease operations to prevent further discrepancies.
    2. Isolate Affected Batches: Identify and quarantine all potentially affected batches and materials.
    3. Notify Stakeholders: Inform production, QA, QC, and senior management about the issue.
    4. Initial Assessment: Conduct a preliminary review of affected processes, materials, and equipment to gather quick insights.
    5. Document Everything: Start an event log to facilitate future investigations and provide a clear timeline of what transpired.

    These actions are essential for minimizing impact and laying the groundwork for a substantive investigation.

    Investigation Workflow (data to collect + how to interpret)

    A structured approach to investigations is paramount for identifying the root causes of process failures:

    1. Data Collection: Gather relevant data, including:
      • Batch records
      • Environmental monitoring logs
      • Equipment calibration records
      • Operator logs and training records
      • Raw material specifications
    2. Data Analysis: Utilize statistical tools to analyze trends and variations. Establish if there are deviations from established baselines or control limits.
    3. Root Cause Identification: Use findings to initiate root cause analysis (RCA) procedures.

    The interpretation of data will inform whether the issue is process-related, material-related, or due to human factors. Documentation of this investigation must adhere to regulatory compliance for future assessments and audits.

    Root Cause Tools (5-Why, Fishbone, Fault Tree) and when to use which

    Selecting the appropriate tool for root cause analysis is essential:

    • 5-Why Analysis: Best used for straightforward issues where the root cause can be traced through successive questioning. Ideal for minor, isolated process failures.
    • Fishbone Diagram: Effective for more complex problems involving multiple categories (materials, methods, etc.). Use this to map out potential causes of process failure thoroughly.
    • Fault Tree Analysis: Useful for systems involving numerous components where failure could occur at different junctures. This is best used in high-risk situations.

    By selecting the right tool, teams can systematically pinpoint failures and develop effective corrective actions.

    CAPA Strategy (correction, corrective action, preventive action)

    Developing a robust CAPA strategy is vital for closing the loop on any identified issues:

    1. Correction: Address the immediate issue (e.g., re-test affected batches, adjust process parameters).
    2. Corrective Action: Implement changes aimed at preventing recurrence, such as redesigning the process or enhancing personnel training.
    3. Preventive Action: Establish ongoing monitoring systems, continuous improvement procedures, and regular audits as a proactive measure.

    Make sure that all CAPA activities are documented in compliance with regulatory requirements, ensuring that there’s a clear audit trail.

    Related Reads

    Control Strategy & Monitoring (SPC/trending, sampling, alarms, verification)

    To maintain process control, a detailed control strategy is essential:

    • Statistical Process Control (SPC): Implement control charts to monitor processes continuously and identify variations before they affect the product quality.
    • Sampling Plans: Establish robust sampling strategies tailored for in-process controls and final product specifications.
    • Alarms and Alerts: Install automated systems to alert operators of deviations from established parameters.
    • Verification: Regularly verify the effectiveness of control measures through audits and assessments.

    A strong control strategy helps ensure ongoing compliance with regulatory standards while mitigating risks associated with non-transferability.

    Validation / Re-qualification / Change Control impact (when needed)

    Any changes made as a result of investigations and CAPA must be considered for validation:

    • Validation: Assess whether changes necessitate re-validation of processes and the associated equipment.
    • Re-Qualification: Confirm that all required qualifications of equipment, processes, and materials are conducted after implementing changes.
    • Change Control: Establish a robust change control procedure to track all modifications and their impact on the process.

    Remaining compliant with validation and re-qualification protocols ensures that the integrity of the process is maintained even after adjustments.

    Inspection Readiness: what evidence to show (records, logs, batch docs, deviations)

    Prepping for regulatory inspections involves ensuring that you have clear, comprehensive documentation:

    • Records: Maintain thorough and accessible records of all operations, including deviations and corrective actions.
    • Logs: Ensure accurate and up-to-date logs of equipment performance, maintenance, and calibration.
    • Batch Documentation: Include all batch records, results from quality control tests, and any deviations and their resolutions.
    • Investigation Reports: Present detailed and precise investigation reports that outline each step taken to understand and resolve non-transferability issues.

    A critical approach to maintaining comprehensive documentation not only aids in inspection readiness but also reinforces process reliability and integrity.

    FAQs

    What are the common symptoms of a non-transferable process?

    Common symptoms include inconsistent product quality, frequent deviations, and challenges during technology transfer sessions.

    How do I contain a process issue immediately?

    Stop production, isolate affected batches, notify stakeholders, perform an initial assessment, and document everything.

    What tools can I use for root cause analysis?

    Tools include 5-Why Analysis for simple issues, Fishbone Diagrams for complex problems, and Fault Tree Analysis for high-risk assessments.

    What should be included in a CAPA strategy?

    A CAPA strategy should include correction, corrective action, and preventive action steps.

    How do I maintain an effective control strategy?

    Implement SPC, create robust sampling plans, use alarms, and regularly verify the effectiveness of control measures.

    When is re-validation necessary?

    Re-validation is necessary when significant changes are made to processes, materials, or equipment that could affect product quality.

    What documentation is essential for inspection readiness?

    Essential documentation includes records, logs, batch documents, and investigation reports that outline resolutions for any deviations.

    How often should training be conducted for personnel?

    Training should be conducted regularly, especially when process changes occur, to ensure that personnel are adequately prepared.

    Pharma Tip:  Process variability exceeds limits during lifecycle optimization – data expectations for filings